The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Early Release of HMGB-1 from Neurons after the Onset of Brain Ischemia
Abstract
The nuclear protein high-mobility group box 1 (HMGB-1) promotes inflammation in sepsis, but little is known about its role in brain ischemia-induced inflammation. We report that HMGB-1 and its receptors, receptor for advanced glycation end products (RAGE), Toll-like receptor 2 (TLR2), and TLR4, were expressed in normal brain and in cultured neurons, endothelia, and glial cells. During middle cerebral artery occlusion (MCAO), in mice, HMGB-1 immunostaining rapidly disappeared from all cells within the striatal ischemic core from 1 h after onset of occlusion. High-mobility group box 1 translocation from nucleus to cytoplasm was observed within the cortical periinfarct regions 2 h after ischemic reperfusion (2 h MCAO). High-mobility group box 1 predominantly translocated to the cytoplasm or disappeared in cells that colabeled with the neuronal marker NeuN. Furthermore, RAGE was robustly expressed in the periinfarct region after MCAO. Cellular release of HMGB-1 was detected by immunoblotting of cerebrospinal fluid as early as 2 h after ischemic reperfusion (2 h MCAO). High-mobility group box 1 released from neurons, in vitro, after glutamate excitotoxicity, maintained biologic activity and induced glial expression of tumor necrosis factor α (TNFα). Anti-HMGB-1 antibody suppressed TNFα upregulation in astrocytes exposed to conditioned media from glutamate-treated neurons. Moreover, TNFα and the cytokine intercellular adhesion molecule-1 increased in cultured glia and endothelial cells, respectively, after adding recombinant HMGB-1. In conclusion, HMGB-1 is released early after ischemic injury from neurons and may contribute to the initial stages of the inflammatory response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Park, J. S., Svetkauskaite, D., He, Q., Kim, J.-Y., Strassheim, D., Ishizaka, A., & Abraham, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,562
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 966
Self-citationHara, H., Friedlander, R. M., Gagliardini, V., Ayata, C., Fink, K., Huang, Z., Shimizu-Sasamata, M., Yuan, J., & Moskowitz, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2007 · Cited by 834
Self-citationInflammation-promoting activity of HMGB1 on human microvascular endothelial cells
Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J. H., & Suffredini, A. F. (2003) · Blood · doi:10.1182/blood-2002-05-1300 · Cited by 737
Goldberg, M., & Choi, D. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03510.1993 · Cited by 706
Cerebral Microvessel Responses to Focal Ischemia
del Zoppo, G. J., & Mabuchi, T. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000078322.96027.78 · Cited by 602
Kim, J.-B., Sig Choi, J., Yu, Y.-M., Nam, K., Piao, C.-S., Kim, S.-W., Lee, M.-H., Han, P.-L., Park, J.-S., & Lee, J.-K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3815-05.2006 · Cited by 579
Faure, E., Equils, O., Sieling, P. A., Thomas, L., Zhang, F. X., Kirschning, C. J., Polentarutti, N., Muzio, M., & Arditi, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11058 · Cited by 560
The cytokine activity of HMGB1
Yang, H., Wang, H., Czura, C. J., & Tracey, K. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1104648 · Cited by 545
Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
Enlimomab Acute Stroke Trial Investigators (2001) · Neurology · doi:10.1212/wnl.57.8.1428 · Cited by 544
MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia
Alessandrini, A., Namura, S., Moskowitz, M. A., & Bonventre, J. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12866 · Cited by 464
Self-citationActivation of gene expression in human neutrophils by high mobility group box 1 protein
Park, J. S., Arcaroli, J., Yum, H.-K., Yang, H., Wang, H., Yang, K.-Y., Choe, K.-H., Strassheim, D., Pitts, T. M., Tracey, K. J., et al. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00322.2002 · Cited by 433
Krams, M., Lees, K. R., Hacke, W., Grieve, A. P., Orgogozo, J.-M., & Ford, G. A. (2003) · Stroke · doi:10.1161/01.str.0000092527.33910.89 · Cited by 430
Cultured astrocytes express toll‐like receptors for bacterial products
Bowman, C. C., Rasley, A., Tranguch, S. L., & Marriott, I. (2003) · Glia · doi:10.1002/glia.10256 · Cited by 395
Cipollone, F., Iezzi, A., Fazia, M., Zucchelli, M., Pini, B., Cuccurullo, C., De Cesare, D., De Blasis, G., Muraro, R., Bei, R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086014.80477.0d · Cited by 377
Namura, S., Iihara, K., Takami, S., Nagata, I., Kikuchi, H., Matsushita, K., Moskowitz, M. A., Bonventre, J. V., & Alessandrini, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181213498 · Cited by 360
Self-citationFriedlander, R. M., Gagliardini, V., Hara, H., Fink, K. B., Li, W., MacDonald, G., Fishman, M. C., Greenberg, A. H., Moskowitz, M. A., & Yuan, J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.933 · Cited by 348
Self-citationHigh mobility group 1 B‐box mediates activation of human endothelium
Treutiger, C. J., Mullins, G. E., Johansson, A. ‐. M., Rouhiainen, A., Rauvala, H. M. E., Erlandsson‐Harris, H., Andersson, U., Yang, H., Tracey, K. J., Andersson, J., et al. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01204.x · Cited by 332
Semino, C., Angelini, G., Poggi, A., & Rubartelli, A. (2005) · Blood · doi:10.1182/blood-2004-10-3906 · Cited by 328
Neuronal Protection in Stroke by an sLe x -Glycosylated Complement Inhibitory Protein
Huang, J., Kim, L. J., Mealey, R., Marsh, H. C., Zhang, Y., Tenner, A. J., Connolly, E. S., & Pinsky, D. J. (1999) · Science · doi:10.1126/science.285.5427.595 · Cited by 315
Gregersen, R., Lambertsen, K., & Finsen, B. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200001000-00009 · Cited by 314
Kalinina, N., Agrotis, A., Antropova, Y., DiVitto, G., Kanellakis, P., Kostolias, G., Ilyinskaya, O., Tararak, E., & Bobik, A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145573.36113.8a · Cited by 275
Justicia, C., Panés, J., Solé, S., Cervera, Á., Deulofeu, R., Chamorro, Á., & Planas, A. M. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000090680.07515.c8 · Cited by 262
HMG1 and 2: architectural DNA-binding proteins
Thomas, J. O. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290395 · Cited by 254
Mackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242 · cited 1×
“To our knowledge, RAGE overexpression in ischemic brain has not yet been reported, although its role in b-amyloid metabolism and Alzheimer’s disease has been studied (Deane et al, 2003; Mackic et al, 1998).”
BackgroundEGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia
Teramoto, T., Qiu, J., Plumier, J.-C., & Moskowitz, M. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17170 · Cited by 226
Self-citationFaraco, G., Fossati, S., Bianchi, M. E., Patrone, M., Pedrazzi, M., Sparatore, B., Moroni, F., & Chiarugi, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04788.x · Cited by 225
Koedel, U., Angele, B., Rupprecht, T., Wagner, H., Roggenkamp, A., Pfister, H.-W., & Kirschning, C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.438 · Cited by 223
Triggers and Mediators of Hemorrhagic Transformation in Cerebral Ischemia
Wang, X., & Lo, E. H. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:3:229 · Cited by 210
Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., & Kasaoka, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00846-9 · Cited by 201
Chen, G., Li, J., Ochani, M., Rendon-Mitchell, B., Qiang, X., Susarla, S., Ulloa, L., Yang, H., Fan, S., Goyert, S. M., et al. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404242 · Cited by 187
Štros, M., Ozaki, T., Bačı́ková, A., Kageyama, H., & Nakagawara, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110233200 · Cited by 181
Marchetti, B., & Abbracchio, M. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.007 · Cited by 175 · cited 2×
“The significance of the inflammatory response to brain ischemia is complex, but there is evidence that in the early phase after ischemia, inflammation contributes to tissue injury, whereas in later stages, inflammation might participate in brain repair (Friedlander et al, 1997; Garau et al, 2005; Hara et al, 1997; Kum…”
BackgroundInterleukin-1 Receptor and Receptor Antagonist Gene Expression After Focal Stroke in Rats
Wang, X., Barone, F. C., Aiyar, N. V., & Feuerstein, G. (1997) · Stroke · doi:10.1161/01.str.28.1.155 · Cited by 161
Lambertsen, K. L., Meldgaard, M., Ladeby, R., & Finsen, B. R. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600014 · Cited by 145
Veldhuis, W. B., Floris, S., van der Meide, P. H., Vos, C. M. P., de Vries, H. E., Dijkstra, C. D., Bär, P. R., & Nicolay, K. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000080701.47016.24 · Cited by 127
Qiu, J., Whalen, M. J., Lowenstein, P. R., Fiskum, G. M., Fahy, B. G., Darwish, R., Aarabi, B., Yuan, J., & Moskowitz, M. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03504.2002 · Cited by 124
Self-citationWu, D.-C., Ye, W., Che, X.-M., & Yang, G. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200009000-00007 · Cited by 117
Wang, X., Wang, H., Xu, L., Rozanski, D. J., Sugawara, T., Chan, P. H., Trzăskos, J. M., & Feuerstein, G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040246 · Cited by 110
Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia
GARAU, A., Bertini, R., Colotta, F., Casilli, F., Bigini, P., Cagnotto, A., Mennini, T., Ghezzi, P., & VILLA, P. (2005) · Cytokine · doi:10.1016/j.cyto.2004.12.014 · Cited by 94
Li, J., Qu, X., & Schmidt, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30870 · Cited by 90
Maier, C. M., Hsieh, L. B., Yu, F., Bracci, P. M., & Chan, P. H. (2004) · Stroke · doi:10.1161/01.str.0000125861.55804.f2 · Cited by 86
Kolev, K., Skopál, J., Simon, L., Csonka, É., Nagy, Z., & Machovich, R. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0070 · Cited by 65
Lambertsen, K. L., Gregersen, R., & Finsen, B. R. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200207000-00004 · Cited by 65
Kumai, Y., Ooboshi, H., Takada, J., Kamouchi, M., Kitazono, T., Egashira, K., Ibayashi, S., & Iida, M. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000143534.76388.3c · Cited by 64
Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice
Schroeter, M., Küry, P., & Jander, S. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00255-9 · Cited by 63
Regenerative Response in Ischemic Brain Restricted by p21cip1/waf1
Qiu, J., Takagi, Y., Harada, J., Rodrigues, N. P., Moskowitz, M. A., Scadden, D. T., & Cheng, T. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031385 · Cited by 59
Self-citationYang, G., Schielke, G. P., Gong, C., Mao, Y. Q., Ge, H., Liu, X., & Betz, A. L. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199910000-00007 · Cited by 50
Lipid unites disparate syndromes of sepsis
Wang, H., Czura, C. J., & Tracey, K. J. (2004) · Nature Medicine · doi:10.1038/nm0204-124 · Cited by 44
Therapeutic Potential of TACE Inhibitors in Stroke
Lovering, F., & Zhang, Y. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007053544147 · Cited by 40
Maślińska, D., Laure‐Kamionowska, M., & Maśliński, S. (2004) · PubMed · Cited by 39
Cited by
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Self-citationHMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Metadata
- Authors
- Qiu, J., Nishimura, M., Wang, Y., Sims, J. R., Qiu, S., Savitz, S. I., Salomone, S., & Moskowitz, M. A.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2007-11-14
- Volume
- 28
- Issue
- 5
- Pages
- 927-938
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2062993799
- Cited by
- 405
- References
- 60
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.